Working… Menu

Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01444846
Recruitment Status : Completed
First Posted : October 3, 2011
Last Update Posted : August 28, 2014
University of Florida
Information provided by (Responsible Party):
Sound Pharmaceuticals, Incorporated

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : December 2013
Actual Study Completion Date : March 2014
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 7, 2016
July 15, 2016
2 November 21, 2017
December 21, 2017
3 January 25, 2018
March 1, 2018
Lynch E, Kil J. Development of Ebselen, a Glutathione Peroxidase Mimic, for the Prevention and Treatment of Noise-Induced Hearing Loss. Semin Hear 2009; 30(1): 047-055

Publications automatically indexed to this study by Identifier (NCT Number):